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A30P and A53T mutations of the presynaptic protein
-synuclein are associated with familial forms of Par-
kinson disease. NMR spectroscopy demonstrates that
Parkinsonism-linked mutations greatly perturb specific
tertiary interactions essential for the native state of
-synuclein. However, -synuclein is not completely un-
folded but exhibits structural fluctuations on the time
scale of secondary structure formation and loses its
native conformation gradually when protein stability
decreases. The redistribution of the ensemble of
-synuclein conformers may underlie toxic gain-of-func-
tion by fostering self-association and altered binding
affinity to ligands and receptors.
Parkinson disease (PD)1 is the most common neurodegenera-
tive movement disorder and is characterized by the loss of
dopaminergic neurons in the substantia nigra and the deposi-
tion of eosinophilic fibrillar proteinaceous aggregates known as
Lewy bodies (1). A central role in this neurological disorder is
played by the abundant, presynaptic 140-residue protein
-synuclein (S). S is the major component of Lewy bodies (2),
and locus triplication causing an increased dosage of the wild
type (wt) S gene potentiates PD (3). Two autosomal domi-
nantly inherited forms of PD are caused by Ala53 to Thr (A53T)
and Ala30 to Pro (A30P) mutations in the S gene, which were
identified in Italian (4) and German kindreds (5), respectively.
Both S mutants display an impaired degradation by chaper-
one-mediated autophagy (6) and share an increased tendency
to form soluble oligomeric intermediates, with the A53T mu-
tant fibrillating even faster than the wt protein (7). Recent
reports suggest that these soluble oligomers, or protofibrils,
may constitute the major toxic species, whereas mature fibrils
may account for a protective function (8). As the loss of S
appears to have minimal effects on development (9), the path-
ogenic effects of mutant S are attributed to a toxic gain-of-
function. These findings are intriguing inasmuch as S has
generally been considered as an intrinsically unstructured pro-
tein (10). Why and how single missense mutations in disor-
dered S accelerate its oligomerization and contribute to the
degeneration of dopamine nerve cells are questions fundamen-
tal to the understanding and treatment of PD.
Recently, it was shown that native S adopts an ensemble of
conformations that are stabilized by long range interactions
(11–14). The latter form an intricate network involving the N
(residues 1–60) and C termini (residues 109–140), which
shields the highly amyloidogenic, non-A component of Alzhei-
mer disease amyloid (NAC) (residues 61–95) from the solvent
(Fig. 1A). Polyamine binding and temperature increase release
the intrinsic tertiary structure of S, leading to a completely
unfolded conformation (13). The relevance of these conditions,
which cause aggregation in vitro, for the development of PD is,
however, unclear. On the other hand, very strong support for
the importance of S in PD comes from the A30P and A53T
mutations in the S gene linked to familial forms of the dis-
ease. Using NMR residual dipolar couplings (RDCs) and para-
magnetic relaxation enhancement (PRE) we demonstrate here
that Parkinsonism-linked mutations greatly perturb the en-
semble of -synuclein conformers. This conformationally al-
tered S may constitute a common mediator in the induction of
PD by both environmental and genetic conditions.
EXPERIMENTAL PROCEDURES
Protein Preparation—PT7 plasmids containing wt, A30P, and A53T
S sequences were a gift from the Lansbury Laboratory, Harvard
Medical School, Cambridge, MA. The following S cysteine-containing
mutants were constructed using the QuikChange site-directed mu-
tagenesis kit (Stratagene) on the above mentioned plasmids: Ala18Cys/
A30P, Ala90Cys/A30P, Ala140Cys/A30P, Ala18Cys/A53T, Ala90Cys/
A53T, and Ala140Cys/A53T. The introduced modifications were further
verified by DNA sequencing. The positions of the cysteine replacements
was distributed along the sequence of S and their introduction did not
cause chemical shift changes in residues other than those surrounding
the point of mutation. 15N-labeled S, wt, and mutants were expressed
in Escherichia coli grown in M9 minimal medium supplemented with
15NH4Cl (Cambridge Isotope Laboratories) and purified as described
previously (15). The final protein working solutions were dialyzed
against buffer A (20 mM Tris-HCl buffer, pH 7.4, 100 mM NaCl).
Spin Labeling of S—The nitroxide spin label chosen for reaction
with the cysteine-containing mutants was MTSL (1-oxy-2,2,5,5-tetra-
methyl-D-pyrroline-3-methyl)-methanethiosulfonate (Toronto Research
Chemicals, Toronto, Ontario, Canada). MTSL had already proven to
efficiently react with S cysteine mutants, and the reaction was carried
out as described previously (13). Paramagnetic samples were measured
at 100 M MTSL-labeled protein concentration, and diamagnetic exper-
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iments were performed with 100 M protein in the presence of 0.5 mM
dithiotreithol (Sigma) to counteract undesirable intensity changes in
certain amide resonances of S caused by addition of the oxidant
ascorbic acid.
Alignment of S in Anisotropic Media—RDCs were measured in S
variants aligned in 5% w/v n-octyl-penta(ethylene glycol)/octanol (C8E5)
(Sigma) (16). Formation of the anisotropic, dilute liquid crystalline
phase was monitored by the splitting of the deuterium signal, which
was 20  2 Hz. Alternatively, alignment was achieved by addition of 10
mg/ml of Pf1 bacteriophage (Asla, Riga, Latvia) with deuterium split-
tings of 9  1 Hz (17).
NMR Measurements—NMR spectra were acquired at 15 °C on
Bruker Avance 600 and 700 NMR spectrometers on a 100 M sample of
S variants in buffer A. Measurement conditions of low temperature
and absence of stirring were chosen to suppress oligomerization. PRE
profiles were derived from the measurement of the peak intensity ratios
from two two-dimensional 15N-1H heteronuclear single quantum coher-
ence (HSQC) NMR spectra aquiered in the presence and absence of the
nitroxide radical. Spectra were recorded using 256 1024 complex data
points in F1 and F2 dimensions with 16 scans per increment and a
relaxation delay of 1.2 s. The spectral widths were 1650 and 5500 Hz in
the 15N and 1H dimensions, respectively. One-bond N-H residual dipo-
lar couplings (DNH) were acquired using the two-dimensional inphase-
antiphase-HSQC sequence (18) under both isotropic and anisotropic
conditions. Spectra were processed and analyzed using nmrPipe (19)
and NMRView (20). DNH values were calculated as the difference be-
tween splittings measured in an aligned sample and those measured in
the isotropic phase (RDCs were not corrected for the negative gyromag-
netic ratio of 15N). RDCs observed under different conditions were
normalized based on the size of the splitting of the deuterium signal
(relative to RDCs for wt S in buffer A).
RESULTS AND DISCUSSION
Familial Mutations Do Not Completely Unfold S—Para-
magnetic enhancement of nuclear spin relaxation by nitroxide
spin labels is a useful technique for deriving distance restrains
for unfolded states of proteins (21). A nitroxide radical causes
broadening of the NMR signals of nearby protons, an effect that
extends as far as 20 Å from modified cysteine residues. As S
lacks cysteine, three different double mutants containing vari-
able single Ala to Cys replacements were constructed for both
the A30P and A53T mutant S. Attachment of the spin label
MTSL to residue 90 greatly attenuated NMR signals of amino
acids in the C terminus of A30P mutant S with peak intensity
ratios between the paramagnetic and the diamagnetic states
(Iparam/Idiam) in the range of 0.5 to 0.9 (Fig. 1B, panel II). This
result indicates that the C-terminal domain of A30P S is
compact, as had been observed previously for wt S (13) and
also holds for the A53T mutant (Fig. 1B, panel V). When the
spin label was attached to residue 140 in the wt protein, the
NMR signals of residues located in the NAC region were con-
siderably broadened, providing support for a back-folding of the
C terminus on this region in wt S (13). There was no evidence
for such a long range interaction in either the A30P or the A53T
mutants (Fig. 1B, panels III and VI). In the A18C spin-labeled
mutant S, intensity ratios as low as 0.5 were observed in the C
terminus, similar to those of wt S (13). In contrast, the relax-
ation enhancement of residues 40–60 was decreased by about
20% for both missense mutants compared with the wt protein
(Fig. 1B, panels I and IV). The reduced paramagnetic broadening
of residues 40–60 suggests that the compaction of theN-terminal
region is reduced in mutant S, in agreement with recent
tryptophan fluorescence energy transfer measurements (22).
Parkinsonism-linked Mutations Greatly Perturb Specific Ter-
tiary Interactions Essential for the Native State of S—Resid-
ual dipolar couplings are exquisitely sensitive to bond vector
orientation and can be measured in a weakly aligned protein,
for which the large internuclear dipolar interactions no longer
average to zero (23). Recently, we reported that RDCs identify
five different domains in wt S (domain I, residues 1–28; do-
main II, residues 33–65; domain III, residues 70–88; domain
IV, residues 95–105; and domain V, the C terminus) and probe
a hydrophobic core comprising the C terminus and domain III
and IV (13). RDCs in PD-linked mutant S were observed with
the A30P and A53T S mutants dissolved in a dilute liquid
crystalline phase of 5% C8E5/octanol. No significant differences
in the chemical shifts of spectra in C8E5/octanol and free in
solution were observed, suggesting that the anisotropic phase
did not appreciably perturb the ensemble of S conformations.
The RDCs in A30P and A53T mutant S were predominantly
positive, with regions displaying relatively large RDCs sepa-
FIG. 1. A, primary sequence of S.
Cyan, brown, and red denote the basic
N-terminal domain, the highly amyloido-
genic non-A component of Alzheimer
disease amyloid region, and the acidic C-
terminal domain. The two Parkinsonism-
linked mutations of S studied in this
work are highlighted. B, NMR PRE of
amide protons in Parkinsonism-linked
mutant S. Intensity ratios (Iparam/Idiam)
of the resonance peaks in 1H-15N HSQC
spectra in the presence (paramagnetic)
and absence (diamagnetic) of the spin la-
bel MTSL at 15 °C. Dashed lines indicate
intensity ratios simulated for a random
coil polypeptide. Decreases in peak inten-
sity ratios that occur far from the site of
spin labeling (10 residues) are indica-
tive of intramolecular long range contacts
between the spin label and distant areas
of sequence. Intensity ratios for A30P/
A18C (panel I), A30P/A90C (panel II),
A30P/A140C (panel III), A53T/A18C
(panel IV), A53T/A90C (panel V), and
A53T/A140C S (panel VI). Solid lines
indicate the intensity ratios observed for
wt S (13).
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rated by residues with RDCs close to zero (Fig. 2, A and B).
Slightly negative couplings were observed for some residues.
The mutant dipolar couplings correlate well with the RDC
domain pattern of the wt protein. In contrast to wt S, however,
the RDCs for domain II (residues 50–62) and domain III (res-
idues 70–94) were strongly reduced. Moreover, residues 20–44
displayed much smaller RDCs in the A30P mutant than in both
wt and A53T mutant S, likely due to the missense mutation in
this region. In the C-terminal domain, the magnitudes of RDCs
were comparable with those in the rest of the protein, in con-
trast to the RDC profile of wt S, in which the effect was higher
by  100%. The dipolar couplings of A30P S were similar to
those of wt S in the presence of 8 M urea (Fig. 2C), whereas the
magnitude of RDCs of A53T S was comparable with that of wt
S in the presence of 4 M urea (Fig. 2D). In addition, the RDC
profile of A18C S, a non-amyloidogenic mutant of S with an
unaltered time course of aggregation (data not shown), was
nearly identical to that of wt S (supplemental Fig. S1). The
results presented in Fig. 2 were reproduced in a second align-
ment medium and at 37 °C (supplemental Fig. S2).
We previously showed that polyamine binding induces a
complete unfolding of wt S. In the A30P and A53T mutants,
however, the strong paramagnetic broadening exerted by a
spin label attached to either residue 18 or 90 on the C-terminal
domain (Fig. 1B, panels I, II, IV, and V) indicate that long
range interactions are not completely abolished. This interpre-
tation is compatible with measurements of the radius of gyra-
tion, which did not differ significantly between wt and mutant
S, but were smaller than for wt S in 8 M urea (24, 25).
Moreover, 15N relaxation time measurements did not indicate
any major long range effects of A30P and A53T replacements
on the backbone flexibility of S (26). Residual dipolar cou-
plings, as reported in this study, were considerably reduced in
the vicinity of both missense mutations. For the A30P muta-
tion, the increased flexibility is in agreement with the reduced
heteronuclear 15N R1
 relaxation rates of backbone amide
groups and a reduced helical propensity for residues 18–31
(26). Besides these local changes, however, a very strong reduc-
tion of dipolar couplings in the C-terminal domain of S was
observed (Fig. 2). As only RDCs and not 15N relaxation time
measurements are sensitive to motions from nano- to microsec-
onds, this suggests that the PD-linked mutations strongly in-
crease structural fluctuations on this time scale, one in which
secondary structures form during protein folding (27). Addi-
tional long range effects were observed for the hydrophobic
NAC region, in which the magnitude of RDCs was considerably
decreased (Figs. 2, A and B) and in which no paramagnetic
broadening was detected by a spin label attached to residue 140
(Fig. 1B, panels III and VI). These results point toward a
reduced shielding of the hydrophobic NAC region in the A30P
and A53T mutant S. In summary, the dipolar couplings dem-
onstrate that the intricate network of long-range interactions is
perturbed in PD-linked mutant S. The protein is more flexible
and able to sample a large range of conformations. Thus, both
A30P and A53T mutant S can overcome more easily the
energetic barrier for self-association, leading to an increased
tendency to oligomerize (7). Formation of mature fibrils, on the
other hand, requires an incorporation of the N terminus in a
-sheet structure, a process hindered by the presence of proline
and thus potentially accounting for a slower rate of fibril for-
mation by the A30P S mutant (7).
S Gradually Loses Its Native Conformation—RDCs and
PREs probe different structural features of S. Backbone RDCs
report on local, backbone conformational propensities (such as
transient elements of secondary structure) in unfolded states of
proteins (28), whereas PREs are sensitive to average, long
range intramolecular distances (21). Therefore, NMR dipolar
couplings and paramagnetic relaxation enhancement by
nearby spin labels correspond to two other techniques com-
monly used to characterize unfolding of proteins: far-ultravio-
let CD to monitor secondary structure content, and fluores-
cence resonance energy transfer to evaluate intramolecular
distances. Although differential scanning calorimetry did not
reveal any thermal transition for either wt or mutant S in the
range 15–110 °C (29), backbone RDCs in the C terminus of S
were greatly reduced upon heating to 37 °C (13) or by the intro-
duction of missense mutations (Fig. 2). As the sites of mutation
are far from the C terminus, the detrimental effects of the mu-
tations must be transmitted through the network of transient
long range interactions to the C-terminal domain of S, such that
conformational restrictions of the backbone are reduced. How-
ever, the retention of strong PRE broadening at 37 °C or in the
presence of missense mutations indicates that dipolar couplings
and PREs have different thermal transition midpoints.
Redistribution of the Ensemble of S Conformers May Un-
derlie Toxic Gain-of-Function—Several biological and biochem-
ical properties underlying the toxic gain-of-function of the fa-
milial mutants of S can now be rationalized in terms of the
different intrinsic structural features of these proteins (Table
I). Recently, it was shown that C-terminal truncation of S is a
FIG. 2. RDCs in mutant S. Backbone N-H dipolar couplings, DNH,
were measured in A30P and A53T mutant S oriented in a 5% C8E5/
octanol mixture at 15 °C. Non-zero dipolar couplings are indicative of
structural and motional restrictions of the protein backbone. A, DNH
profile for A30P S (bars) and wt S (line) in buffer A (20 mM Tris-HCl
buffer, pH 7.4, 100 mM NaCl). B, DNH profile for A53T S (bars) and wt
S (line) in buffer A. C, DNH couplings in the C terminus of A30P S in
buffer A (bars) and of wt S in buffer A  8 M urea (line). D, DNH
couplings in the C terminus of A53T S in buffer A (bars) and of wt S
in buffer A  4 M urea (line). RDC domains identified in wt S (domain
I, residues 1–28; domain II, residues 33–65; domain III, residues 70–
88; domain IV, residues 95–105; and domain V, the C terminus) (13) are
indicated.
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normal cellular process and that the generation and accumu-
lation of truncated S may be involved in the initiation and
progression of S aggregation in vivo. Residues 119–123 were
identified as potential cleavage sites and the accumulation of
truncated S was enhanced by the expression of mutant S
(30). These findings may be explained by the results of the pres-
ent study. Although the truncation site is far from the A30P and
A53T missense mutations, the destabilization of S tertiary
structure may allow proteases to degrade the S C terminus
more efficiently. This destabilization may also be the source for
the increased affinity of lysosomal chaperone-mediated auto-
phagy receptors for mutant S, recognizing the sequence
95VKKDQ99 present in the C terminus of S and thereby causing
an impairment in protein catabolism (6). Regarding self-
association, an increased tendency to form dimers, oligomers,
and annular protofibrills has been evidenced for both PD-linked
mutants (7, 31, 32), which may as well be explained in terms of
our findings. The decreased shielding of the highly hydrophobic
NAC region due to the reduction of long range interactions allows
A30P and A53Tmutant S to preferentially expose this region to
the solvent, facilitating self-association.
We conclude that the redistribution of the structural ensem-
ble of the A30P and A53T S mutants potentiates oligomeriza-
tion and modulates binding to ligands, proteases, and recep-
tors. This effect may account for the toxic gain-of-function of
familial Parkinsonism-linked mutant S. Conformationally al-
tered S may constitute a general molecular mechanism un-
derlying the induction of PD by environmental and genetic
conditions (Fig. 3). Thus, agents specifically designed to stabi-
lize the native state of S may prove useful in impeding or
reversing its pathologic aggregation in both idiopathic and
familial forms of Parkinson disease.
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FIG. 3. Proposed scheme for the increased neurotoxicity of S
genetic mutants. In this study we demonstrated that the two familial
Parkinsons disease associated mutants A30P and A53T perturb the
long range interactions essential for the native state of S. Long range
interactions characterize the auto-inhibited native state of S, main-
taining the protein in a soluble innocuous state (13). Mutant S can
overcome more easily the energetic barrier for self-association, leading
to an increased tendency to oligomerize. Polyamine binding and high
temperature, conditions that in vitro enhance S aggregation, induce a
completely unfolded structure (13). Therefore we propose that redistri-
bution of the ensemble of S conformers, such that the highly amyloid-
genic NAC region becomes exposed to the solvent, and -sheet-rich
conformations are adopted more easily, represents the common mech-
anism for both genetically linked and environmentally induced S
oligomerization in Parkinson disease.
TABLE I
Distinctive features of S-mediated pathogenesis correlate with the
properties of A30P and A53T mutants
Characteristics associated with the increased neurotoxicity
of A30P and A53T
Biological features Reduced cell viability in cell culture
models (33)
Increased inhibition of proteasomal
activity (34, 35)
Impaired protein degradation via
chaperone-mediated autophagy (6)
Enhanced in vivo C-terminal
truncation (30)
Biochemical features Facilitated formation of dimers (31)
Acceleration of oligomerization (7)
Presence of annular protofibrills (32)
Rapid fibrillation (only A53T) (7)
Higher vesicle permeabilization
activity (36)
Structural features Perturbed autoinhibitory long range
interactions (this work)
Increased backbone flexibility in the
nano- to microsecond time scale
(this work)
Increased exposure of NAC region
(this work)
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